Remotely Monitored Exercise Program in Pregnant Women With Obesity (GROB)

June 20, 2022 updated by: Universidade do Porto

Remotely Monitored and Exercise Program in Gestational Weight Gain in Pregnant Women With Obesity

Pregnant women with obesity will be invited to participate in structured home-based exercise programme, remotely monitored

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Pregnant women with obesity will be invited to participate in structured home-based exercise programme, remotely monitored. The remote system use inertial motion trackers, digitizes pregnant women motion and provides real-time feedback on performance through a mobile app. It also includes a web-based platform that allows the clinical team to prescribe, monitor and adapt the exercise program remotely. This way, the system allows patients to perform independent exercise program at home without the need for constant therapist supervision, ensuring remote monitoring throughout the rehabilitation program. The exercise programme will be performed since the first gestational trimester until delivery.

Data of gestational weight gain, gestational diabetes mellitus, low back pain and quality of life will be colected.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant women with obesity (BMI ≥ 30 kg/m2) at first gestational trimester

Exclusion Criteria:

  • pre-pregnancy BMI < 30 kg/m2;
  • previous bariatric surgery;
  • hemodynamically significant heart disease;
  • restrictive lung disease;
  • incompetent cervix or cerclage;
  • multiple gestation;
  • persistent second- or third-trimester bleeding;
  • placenta previa after 26 weeks of gestation;
  • premature labor during the current pregnancy;
  • ruptured membranes;
  • preeclampsia or pregnancy-induced hypertension;
  • severe anemia;
  • inability to read and understand Portuguese; ->15 weeks gestation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control intervention
The control group will receive the standard prenatal care in Hospital Center of São Joao (CHUSJ). The standard prenatal care will be regular appointments with obstetrician and midwife nurses, ultrasounds and nutritional appointments. The pregnant women in control group will also receive a pamphlet with the benefits of physical exercise during pregnancy and recommendations for adequate gestational weight gain. Pregnant women in control group will not be discouraged from exercising on their own.
Experimental: Exercise intervention
The exercise group intervention will perform home-based remotely monitored exercise
The pregnant women will perform a home-based structured exercise programme. The exercise will be remotely monitored since the first gestational trimester until delivery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gestational Weight Gain
Time Frame: At delivery
Using portable digital scale (Tantita InnerScan BC-545). Gestational weight gain will be calculated as the difference between maternal weight at last appointment (36-39 gestational weeks) and pre-pregnancy weight.
At delivery
Excessive gestational weight gain
Time Frame: At delivery
The adequate gestational weight gain in pregnant women with obesity should not exceed 9kg in entire pregnancy, the values over these thresholds will be considered excessive gestational weight gain.
At delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Low Back Pain
Time Frame: At first, second and third gestational trimester
Oswestry Low Back Pain Disability Questionnaire (ODI v2.0)
At first, second and third gestational trimester
Subjective Physical Activity assessment
Time Frame: At first, second and third gestational trimester
Pregnancy Physical Activity Questionnaire (PPAQ) is a self-reported questionnaire. The objective is measure the type and intensity of pregnant women physical activity.
At first, second and third gestational trimester
Objective Physical Activity assessment
Time Frame: At first, second and third gestational trimester
Accelerometry, is a device that monitors the acceleration of body segments, it is considered the gold standard with regard to objectivity and reliability (ICC:0.661-0.806)
At first, second and third gestational trimester
Gestational Diabetes Mellitus
Time Frame: Second gestational trimester
The presence of gestational diabetes mellitus will be assessed between 24-28 gestation weeks, through the Oral Glucose Tolerance Test. Blood sampling for fasting glucose concentrations will be taken after a 10 hour overnight fast, and glucose tolerance will measured by a 2 hours 75 mg per-oral glucose tolerance test. GDM will be diagnosed as fasting glucose ≥ 126 mg/dl or 2h concentration ≥ 200 mg/dl.
Second gestational trimester
Quality of Life Assessment
Time Frame: At first, second and third gestational trimester
COOP-Quality of life during Pregnancy Questionnaire
At first, second and third gestational trimester
Pelvic Floor and sexual disorders during pregnancy
Time Frame: At first, second and third gestational trimester
Assessment of Pelvic Floor Disorders and Their Risk Factors During Pregnancy and Postpartum Questionnaire
At first, second and third gestational trimester

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 1, 2022

Primary Completion (Anticipated)

December 1, 2022

Study Completion (Anticipated)

May 1, 2023

Study Registration Dates

First Submitted

March 3, 2022

First Submitted That Met QC Criteria

April 11, 2022

First Posted (Actual)

April 15, 2022

Study Record Updates

Last Update Posted (Actual)

June 22, 2022

Last Update Submitted That Met QC Criteria

June 20, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on Remote Exercise

Subscribe